Special Issue "Quality of Life, Survival, and Recurrence Patterns Following Brain Metastases"

A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Survivorship and Quality of Life".

Deadline for manuscript submissions: closed (6 November 2023) | Viewed by 146

Special Issue Editor

Department of Radiation Oncology and Molecular Radiation Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
Interests: brain metastases; brain tumors; glioblastoma; image-guided radiation therapy

Special Issue Information

Dear Colleagues, 

A Special Issue of Cancers focused on brain metastasis will explore evolving strategies to improve long-term survival and quality of life of patients with spread of cancer to the brain. Over the past decade, outcome has improved for patients with brain metastasis with the aggressive management of intracranial disease with radiosurgery and surgery in the context of the concurrent use of improved systemic therapies including immune-oncology drugs, molecularly targeted agents, and cytotoxic chemotherapy. A multi-disciplinary selection of articles will describe optimal current approaches and pathways to better results through improving imaging detection and assessment of response; optimal use of local therapy to balance risk, tumor control, and quality of life; and the use of systemic pharmaceuticals to improve both brain control and survival.

Dr. Lawrence Richard Kleinberg
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • brain metastases
  • brain tumors
  • survival
  • quality of life
  • recurrence patterns

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop